Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03217747
Title Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

prostate cancer

Advanced Solid Tumor


Avelumab + PF-04518600 + Utomilumab

Avelumab + Utomilumab

Avelumab + PF-04518600

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.